1. Home
  2. GPCR vs DQ Comparison

GPCR vs DQ Comparison

Compare GPCR & DQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPCR
  • DQ
  • Stock Information
  • Founded
  • GPCR 2016
  • DQ 2006
  • Country
  • GPCR United States
  • DQ China
  • Employees
  • GPCR N/A
  • DQ N/A
  • Industry
  • GPCR
  • DQ Semiconductors
  • Sector
  • GPCR
  • DQ Technology
  • Exchange
  • GPCR Nasdaq
  • DQ Nasdaq
  • Market Cap
  • GPCR 1.8B
  • DQ 1.4B
  • IPO Year
  • GPCR 2023
  • DQ 2010
  • Fundamental
  • Price
  • GPCR $34.17
  • DQ $19.22
  • Analyst Decision
  • GPCR Buy
  • DQ Hold
  • Analyst Count
  • GPCR 5
  • DQ 5
  • Target Price
  • GPCR $86.80
  • DQ $20.31
  • AVG Volume (30 Days)
  • GPCR 677.5K
  • DQ 2.5M
  • Earning Date
  • GPCR 11-13-2024
  • DQ 10-30-2024
  • Dividend Yield
  • GPCR N/A
  • DQ N/A
  • EPS Growth
  • GPCR N/A
  • DQ N/A
  • EPS
  • GPCR N/A
  • DQ N/A
  • Revenue
  • GPCR N/A
  • DQ $1,310,019,000.00
  • Revenue This Year
  • GPCR N/A
  • DQ N/A
  • Revenue Next Year
  • GPCR N/A
  • DQ $47.79
  • P/E Ratio
  • GPCR N/A
  • DQ N/A
  • Revenue Growth
  • GPCR N/A
  • DQ N/A
  • 52 Week Low
  • GPCR $26.61
  • DQ $13.62
  • 52 Week High
  • GPCR $66.38
  • DQ $30.85
  • Technical
  • Relative Strength Index (RSI)
  • GPCR 35.81
  • DQ 42.58
  • Support Level
  • GPCR $33.85
  • DQ $20.50
  • Resistance Level
  • GPCR $38.48
  • DQ $22.31
  • Average True Range (ATR)
  • GPCR 2.62
  • DQ 1.72
  • MACD
  • GPCR -0.36
  • DQ -0.54
  • Stochastic Oscillator
  • GPCR 3.67
  • DQ 0.29

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company aiming to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small-molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073 and LTSE-2578.

About DQ DAQO New Energy Corp.

Daqo New Energy Corp is a polysilicon manufacturer based in China. The company manufactures and sells high-purity polysilicon to manufacturers who use it to make ingots, cells, and modules for solar power solutions. The polysilicon is packaged to meet crucible stacking, pulling, and solidification needs. All of the company's revenues come from the People's Republic of China.

Share on Social Networks: